Get started

Vaccine

MRNA & end of the bulls?MRNA has had a few wild weeks going up from $120 to $170. I believe this could be the end of the bullishness and it may do a correction. Why do I believe this could happen? MRNA hit historic resistance of $170, after hitting that mark it began dropping. This resistance seems like it can hold. RSI is bounced off the 70 mark on the daily chart. RSI is overbought on the 4HR chart EMA's are beginning to cross over on the hour charts. This could be a tiny correction and just bounce off $160 before continuing its path to $200 so I would keep a close eye on the stock. What I am looking for right now is: 1st support - $160 2nd support - $139_$145 3rd support - $120 At this point MRNA going back down to $100 or even lower seems incredibly unlikely. Moderna's earnings arent too far away so that could act as a catalyzer that will continue the growth. In short I believe that MRNA could have hit the resistance and it will either go down to the listed supports or if it stays in these levels then it will most likely stay like this till earnings come which will tell what direction it is going to go from here. Please comment down your ideas and thoughts on this, I would appreciate any criticism you may have on the charts and analysis, and looking forward to your comments! I am not a financial advisor, these are my personal ideas an thoughts please do your own research before buying a stock.
NASDAQ:MRNAShort
by Geckie
10
JOHNSON & JOHNSON (JNJ)In my work, I always try to combine fundamental analysis and technical analysis. They are both important, especially on a topic as important as the covid vaccine. Johnson & Johnson is about to be marketed, after the approval of the EMA on 11 March. Exactly after the announcement, I bought the stock. The JnJ vaccine has a much lower distribution cost than Pfizer since it can be stored at refrigerator temperatures, like AstraZeneca. The difference is in the prestige and history that the company has. Moreover, the share according to the average of analysts, still has ample room for growth, with an average target of $ 185 and a second "high" at $ 200. Technically speaking, the price bounced off the bullish support trendline on Thursday, March 4th, and then broke the resistance trendline on the 12th, exactly the day after the announcement of the EMA's approval. The trend is clearly bullish, but, even keeping in mind the analysts' opinion, I believe the first target in area 170 is more likely. If everything goes well with the vaccine, the analyst targets could be greatly raised. It is a different trade, to be constantly monitored with a trailing stop, in case there will be any hitches or cases of a block, as happened for AstraZeneca. Such an open market scenario would cause a crash, so you have to be ready to get out quickly. Lazy Bull 1st target: 170 2nd target: 180 3rd target: 200 DISCLAIMER: I am not a financial advisor nor a CPA. These posts, videos, and any other contents are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
NYSE:JNJLong
by LazyBull5
2
$JNJ will bounce - Dip opportunityI love JNJ long and believe that they are going to be fine with the recent COVID-related dip. Their vaccine could do more damage than AstraZeneca's and governments will still buy it in order to herd the sheep. You need to understand that JNJ is so much more than a vaccine company. Expect this stock to go back up to the $167 level, as well as breaking the $170 level as well. A great swing trade (buy covid dips), and I also love this long-term. Lots of money to be made here! *Not a financial advisor. **Don't judge me on my winners. Judge me on my losers, because there are so few.
NYSE:JNJLong
by kambach
6
PFIZER: Covid's Decision !On PFIZER , H1 timeframe price is around a critical decision zone, so what can we expect here: 1. Global Recover: If the fundamentals are positive, then the chart will be bullish and we will go into the 1st scenario where price continues to trade inside the channel until it reaches the resistance zone were we can look for sell setups. 2. Failure: Unlike the first one, the price hasn't broken aggressively yet the resistance where it's standing, so it can move downward into the zone, trade there for a couple of days since it doesn't have great volatility and goes down bearishly to reach the support. This scenario can be imagined if the global reaction to the vaccine remain negative or any unprecedented medical issue happens. Until then, Trade Safe and Best of Luck ! MacroForex
NYSE:PFE
by Therealsmaira
Covid vaccine play 🚀🚀🚀VBIV CEO Baxter said on a feb 5 2021 podcast that human trials were to begin in the next couple of weeks for their single dose monovalent covid vaccine vbi-2902, which received $56 Million from Canada to produce a vaccine. Today moderna announced forecasted sales of ~$18 Billion just from covid vaccine sales. Once VBi announces initiation of human trials for the ph1/2 study planned in Canada, I’m expecting a sizeable move to the upside. Cup and handle - handle retraced to FIBO 618 retrace net which is a nice area to see bounce. I see potential to test The previous high of $6.98 as perceptive advisors did not sell any shares after loading bigly sub-$1 prior to that run which was over 1000% incl trade for them. This shows they expect SP to move significantly higher or fhey would have sold a percentage to re add on dips after that massive run. With all the catalysts in 2021, GBM treatment with eVLP , SCI-b-vac and hepB therapeutic, pan-corona vaccine and this single dose vaccine, I see no reason why this can’t be double digits by year end. Please like and follow! 🚀🚀🚀🚀 Disclosure: not investment advice as I am not a financial advisor. This information is to be used for educational purposes only.
VLong
by follow_the_money
2
Coffee, Global Agriculture Inflation BoomNotice the major multi-year higher low formed in 2019, followed by the rounding basing pattern and subsequent breakout outside of the multi-year triangle. The higher low in 2019, before the Covid deflation crash, tells me the agriculture complex was already bottoming ahead of Covid and now has a full head of steam. Corn, Soybeans, Sugar, Fertilizer have all been ripping to the upside like mad. Way to play coffee is through the ETF NIB Not investment advice. DYODD
ICEUS:KC1!Long
by Ludwig_Von_Mises
Are You Positioned for Quad 2? I hope you're readyWe're already in the midst of record runs in the equity and commodity markets but as bubbly as it seems, its not over. We are in an environment that not many people are familiar with. The last time Growth and Inflation on a global scale were accelerating as fast as they are now was immediately after World War 2. Previous commodity cycles were sparked by 1 or 2 catalysts. The current macro setup has nearly the most accommodative and bullish catalysts for global growth and inflation that we could imagine. Fed on autopilot, Fiscal out the wazoo, supply chain disruptions and shortages everywhere, all major political interests want a weaker dollar. Given that is the case and YoY GDP will probably show about +10% and CPI +3% in the 2nd Quarter, there's a good chance this current run, especially for commodities, could continue for a couple more months before a major correction. Things I have been and remain bullish on: Potash, Sugar, Wheat, Soybeans, Corn, Cocoa, Coffee, Orange Juice, Copper, Uranium, Crude Oil, Natural Gas. I've added to my exposure recently Aluminum, Nickel, and Coal.
CBOT:ZW1!Long
by Ludwig_Von_Mises
NVAX coming back 400+ soonHey guys so NVAX had a nice bounce today from its open at 240 and closed at 273.98. It was a solid day I'm not too happy about the volume though due to it being pretty low. The stock is not going to have a tremendous move if there is no volume. We need to have above average volume to see a nice spike above 300 again. Now with the EU news coming possibly end of this week or next week I believe NVAX is going to skyrocket. I am still staying strong with my bullish target of 400 by end of February due to the amount of volume and buy orders we are going to have with the incredible EU deal. Even if EU does not come out this week we still are very oversold on the indicators and have destroyed Pfizer’s new SA variant numbers which show only 20% effectiveness on the new variant. Ours is 60% if you forgot, so we are in good shape right now do not be intimidated by shorts and hold strong!!
NASDAQ:NVAXLong
by Stockguy222
5
ORAL PILL VACCINE !!! COVID 19-01/28/2021--------- BULL FLAG ON DAILY 01-29-2021-------BULL FLAG ON HOURLY FEBRUARY 3RD PRESENTATION ON CONFERENCE WITH DR. FAUCI AND OTHER LEGENDS ORAL VACCINE ------ COVID 19 PILL VACCINE ----- NOROVIRUS ----- FLU---- JNJ COLLABORATION---- NEXT WEEK IF FOLLOWED THE TREND AND NEWS are POSITIVE --- $16 IS EASY !!! IF FALL DOWN --- WILL GO TO $10.45 AND STAY THERE TILL ANOTHER DIRECTION! POSSIBLE SHORT SQUEEZE IF IT HITS $16, 33.97 MILLION SHORT AVAILABLE.. ONE OF THE MOST SHORTED TICKER IN 2020.
NASDAQ:VXRTLong
by Hope_Best
4